IARS2 Antibodies

Santa Cruz Biotechnology delivers a wide array of IARS2 monoclonal antibodies for research focused on understanding mitochondrial isoleucyl-tRNA synthetase 2 (IARS2). IARS2 Antibodies targeting IARS2 are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IARS2 plays a fundamental role in mitochondrial protein synthesis and is essential for maintaining proper mitochondrial function. The protein facilitates the translation of mitochondrial mRNA, which drives the production of key components in the electron transport chain and ATP generation. Mutations in IARS2 have been linked to various mitochondrial diseases and metabolic disorders, making it a significant target for scientific investigation. Research into IARS2 continues to reveal new insights about mitochondrial biology and its impact on cellular health. Understanding IARS2 function helps illuminate the mechanisms behind mitochondrial diseases and potential therapeutic approaches. Investigating IARS2 expression and activity patterns provides valuable information about cellular energy metabolism and protein synthesis pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of mitochondrial biology and its implications for human health.